[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.89.187. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 21, 1987

Isoniazid Prophylaxis-Reply

Author Affiliations

Mount Sinai School of Medicine City University of New York

Mount Sinai School of Medicine City University of New York

JAMA. 1987;258(7):911. doi:10.1001/jama.1987.03400070048024
Abstract

In Reply.—  The study Dr Moulding refers to, from which we derived the risks of isoniazid hepatitis, was the Public Health Service cooperative surveillance study.1 The investigators found 0.578 deaths per 1000 isoniazid recipients. We calculated the 95% confidence interval to range from 0.2 to 1.0 deaths per 1000 isoniazid recipients. Among other well-documented studies that were sufficiently large to uncover this low risk, the rates vary from 0.1 to 0.9 deaths per 1000 isoniazid recipients.2-4 Consequently, we used 0.578 deaths per 1000 isoniazid recipients as our best estimate, and used 0.1 and 1.0 deaths per 1000 isoniazid recipients as the low and high estimates in our sensitivity analysis. Even at the high estimate, the decision favors taking isoniazid.Dr Moulding suggests that the tuberculosis case fatality rate may be lower in people compliant enough to have taken isoniazid chemoprophylaxis. To our knowledge, this hypothesis has not been

×